18 Mar

Tilray Reports Its Fourth-Quarter Earnings

WRITTEN BY Adam Jones

Tilray earnings

Tilray (TLRY) reported its quarterly earnings after the market closed. The company reported a total quarterly sales of $15.5, which increased nearly 203.8% year-over-year. The company sold a total 2,053 kilograms at an average net selling price of about $7.5 per gram during the quarter, compared with 694 kilograms a year ago at an average price of about $7.1 per gram.

The company’s revenue gains failed to turn into profits with Tilray reporting an EBITDA loss of $17.8 million, compared to an EBITDA loss of about $2.1 million in Q4 last year.

Tilray reported a net loss of $31 million, which expanded from about $2.9 million a year ago and translated into a loss per share of $0.33 versus $0.04 a year ago.

The company also reported its full-year results. In 2018, Tilray’s total loss stood at $67 million, which expanded from $7.8 million in 2017. Its loss per share stood at $0.82, compared about $0.1 in 2017.

Tilray was trading about 4.5% higher in the after-market hours today following the company’s earnings release. On the other hand, peer (HMMJ) Cronos Group (CRON) was up 0.8%, Canopy Growth (WEED) was flat, and Aphria (APHA) was down about 1.8%.

Latest articles

Investors have been holding their breath for a Fed rate cut for a while now. But are they prepared in the event that that doesn't happen?

Innovative Industrial Properties (IIPR) continued to slump on July 22. The stock lost almost 6.8% of its value on the day.

22 Jul

Why AT&T Stock Is Down 2.2% Today

WRITTEN BY Ambrish Shah

AT&T stock (T) was trading at $32.14 with a 2.0% loss for the day. Earlier today, it posted a low of $32.08. Is the stock overvalued right now?

The Walt Disney Company’s (DIS) superhero film Avengers: Endgame has finally surpassed the record set by James Cameron’s Avatar.

22 Jul

Why Durect Corporation Is Soaring Today

WRITTEN BY Margaret Patrick

On July 22, Durect Corporation (DRRX) entered into a collaboration with HIV leader Gilead Sciences (GILD).

Pure Alpha, the flagship fund of Ray Dalio’s Bridgewater Associates, fell 4.9% in the first half, the Financial Times reported.